MNK News and Press, Mallinckrodt plc From 04/28/23

The Buxton Helmsley Group, Inc. (together with certain of its affiliates, “BHG” or “we”), the New York City-based investment advisor to clients with financial interests in Mallinckrodt Plc. (“Mallinckrodt” or the “Company”) (NYSE: MNK), toda...

Highlights: Record First Quarter Sales of $546 Million, 5 Percent Above Prior Year Operating Income of $63 Million, Increased 43 Percent Sequentially Cash Flow from Operations Improved by $33 Million from Prior Year Reorganization and New Segmentation Implemented Announced...

Mallinckrodt to Report Earnings Results for First Quarter 2023 PR Newswire DUBLIN , April 24, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that it will report first quarter 2023 ear...

NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE: MTX) (“MTI” or “the Company”) today announced that it has entered into three long-term precipitated calcium carbonate (PCC) supply agreements that will further expand the Company’s Sp...

NEW YORK, April 12, 2023 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE: MTX) (“MTI” or “the Company”) announced today that it will release results for its fourth quarter ended April 2, 2023, on Thursday, April 27, 2023, after the market close. The Company will h...

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the National Kidney Foundation (NKF) 2023 Spring Clinical Meeting (SCM) PR Newswire – Two scientific abstracts spanning clinical and healt...

NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE: MTX), a leading technology-driven specialty minerals company will host an Investor Day on Wednesday, May 24, at 8:30 a.m. EST at the New York Stock Exchange. The webcast portion of this event will conclude at 11:30 a.m...

2023-03-23 05:51:28 ET The following slide deck was published by Mallinckrodt plc in conjunction with this event. For further details see: Mallinckrodt (MNK) Presents At 43rd Annual Healthcare Conference - Slideshow

Mallinckrodt to Present New Retrospective Data on Effect of Acthar® Gel (Repository Corticotropin Injection) to Reduce Corticosteroid Use and Burden for Advanced Sarcoidosis at the Academy of Managed Care Pharmacy (AMCP) 2023 Annual Meeting PR Newswire – Findings fro...

2023-03-13 23:58:45 ET Summary Silence Therapeutics is an underfollowed British siRNA company focusing on cardiovascular and autoimmune diseases. Silence Therapeutics is a de-risked investment opportunity with significant potential upside, supported by its robust pipeline, strateg...